J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2006

Papers In Press, published online ahead of print August 16, 2006
J. Lipid Res., doi:10.1194/jlr.M600297-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M600297-JLR200v1
47/11/2492    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaidukov, L.
Right arrow Articles by Tawfik, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaidukov, L.
Right arrow Articles by Tawfik, D. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on July 10, 2006
Revised on August 15, 2006
Accepted on August 15, 2006

The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, stimulation of lipo-lactonase, and macrophage cholesterol efflux

Leonid Gaidukov, Mira Rosenblat, Michael Aviram, and Dan S. Tawfik

Biochemistry, Weizmann Institute of Science, Rehovot 76100

Corresponding Author: leonid.gaydukov{at}weizmann.ac.il

Serum paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated enzyme exhibiting potentially antiatherogenic properties. Here we examined the common PON1 192R/Q human polymorphism. Despite numerous studies, the effect of this polymorphism on the antiatherogenic potential of PON1 is yet unresolved. Our structural model suggests that amino acid 192 comprises part of the HDL-anchoring surface and active site of PON1. Based on our findings that PON1 is an interfacially activated lipo-lactonase that selectively binds HDL carrying apolipoprotein A-I (apoA-I), and is thereby greatly stabilized and catalytically activated, we examined the interaction of the PON1-192 isozymes with reconstituted HDL-apoA-I particles. We found that PON1 position 192 is indeed involved in HDL binding. The PON1-192Q binds HDL with a 3-fold lower affinity than the R isozyme, and consequently exhibits significantly reduced stability, lipo-lactonase activity and macrophage cholesterol efflux. We also observed the lower affinity and stability of the 192Q versus the 192R isozymes in sera of individuals belonging to the corresponding genotypes. The observed differences in the properties of PON1 192R/Q isozymes provide a basis for further analysis of the contribution of the 192R/Q polymorphism to the susceptibility to atherosclerosis, although other factors such as the overall levels of PON1 may play a more significant role.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Chambers
PON1 multitasks to protect health
PNAS, September 2, 2008; 105(35): 12639 - 12640.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
J. F. Teiber, S. Horke, D. C. Haines, P. K. Chowdhary, J. Xiao, G. L. Kramer, R. W. Haley, and D. I. Draganov
Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-L-Homoserine Lactone
Infect. Immun., June 1, 2008; 76(6): 2512 - 2519.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. Bhattacharyya, S. J. Nicholls, E. J. Topol, R. Zhang, X. Yang, D. Schmitt, X. Fu, M. Shao, D. M. Brennan, S. G. Ellis, et al.
Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk
JAMA, March 19, 2008; 299(11): 1265 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Gaidukov and D. S. Tawfik
The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity
J. Lipid Res., July 1, 2007; 48(7): 1637 - 1646.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.